Literature DB >> 7249391

Platelet activating factor: an inhibitor of neutrophil activation?

M C O'Donnell, J N Siegel, B A Fiedel.   

Abstract

Preparations of platelet activating factor (PAF) derived by methanolic extraction of supernatants from antigen-challenged rabbit basophils proved capable of activating platelets while concurrently inhibiting neutrophil aggregation/secretion stimulated by biologically active F-Met peptides, ionophore A23187, or zymosan-treated serum. This inhibition was non-cytotoxic and species-non-specific. When these PAF preparations were analysed using thin-layer chromatography, multiple lipids were detected. Both platelet-stimulating as well as neutrophil-inhibitory activity was present in a lipid component migrating at an RF consistent with native PAF; however, these biological activities were not limited only to PAF and, indeed, could also be detected in lipid with solubility characteristics more closely related to a lysophosphatide than to native PAF. These data are compatible with the belief that native PAF may belong to a family of biologically active lipids differing somewhat in physico-chemical properties. Moreover, these data illustrate that PAF and/or PAF-like molecules may also demonstrate a biological activity distinct from their effects upon the platelet.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249391      PMCID: PMC1537118     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes.

Authors:  J I Gallin; R A Clark; H R Kimball
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

2.  The glomerular permeability determined by dextran clearance using Sephadex gel filtration.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

3.  Letter: Aggregation of human platelets by platelet-activating factor.

Authors:  J Benveniste; J P Le Couedic; P Kamoun
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

4.  IgE-induced release of a platelet-activating factor from rabbit lung.

Authors:  T C Kravis; P M Henson
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

5.  Inhibition and potentiation of platelet function by lysolecithin.

Authors:  J H Joist; G Dolezel; M P Cucuianu; E E Nishizawa; J F Mustard
Journal:  Blood       Date:  1977-01       Impact factor: 22.113

6.  Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes.

Authors:  G Brittinger; R Hirschhorn; S D Douglas; G Weissmann
Journal:  J Cell Biol       Date:  1968-05       Impact factor: 10.539

7.  Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response.

Authors:  P M Henson
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

8.  Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets.

Authors:  P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

9.  Release of vasoactive amines from rabbit platelets induced by sensitized mononuclear leukocytes and antigen.

Authors:  P M Henson
Journal:  J Exp Med       Date:  1970-02       Impact factor: 14.307

10.  Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.

Authors:  J Benveniste; P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  2 in total

1.  Effect of synthetic PAF-acether on human neutrophil function.

Authors:  B M Czarnetzki; J Benveniste
Journal:  Agents Actions       Date:  1981-12

2.  Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation.

Authors:  Emily J Welch; Ram P Naikawadi; Zhenyu Li; Phoebe Lin; Satoshi Ishii; Takao Shimizu; Chinnaswamy Tiruppathi; Xiaoping Du; Papasani V Subbaiah; Richard D Ye
Journal:  Mol Pharmacol       Date:  2008-10-17       Impact factor: 4.436

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.